Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
SMARCB1-deficient cancers: novel molecular insights and therapeutic vulnerabilities
Simple Summary Loss of SMARCB1 has been identified as the sole mutation in a number of
rare pediatric and adult cancers, most of which have a poor prognosis despite intensive …
rare pediatric and adult cancers, most of which have a poor prognosis despite intensive …
Artificial intelligence for precision oncology
Precision oncology is an innovative approach to cancer care in which diagnosis, prognosis,
and treatment are informed by the individual patient's genetic and molecular profile. The …
and treatment are informed by the individual patient's genetic and molecular profile. The …
[HTML][HTML] Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
Atypical teratoid rhabdoid tumors (AT/RT) are malignant central nervous system (CNS)
tumors that occur mostly in young children and have historically carried a very poor …
tumors that occur mostly in young children and have historically carried a very poor …
Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics
PD Johann, L Altendorf, EM Efremova, T Holsten… - Acta …, 2023 - Springer
Atypical teratoid/rhabdoid tumors (AT/RT) are the most common malignant brain tumors
manifesting in infancy. They split into four molecular types. The major three (AT/RT-SHH …
manifesting in infancy. They split into four molecular types. The major three (AT/RT-SHH …
Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center …
Methylation profiling has radically transformed our understanding of tumors previously
called central nervous system primitive neuro-ectodermal tumors (CNS-PNET). While this …
called central nervous system primitive neuro-ectodermal tumors (CNS-PNET). While this …
Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities
I Paassen, J Williams, C Ríos Arceo, F Ringnalda… - Oncogene, 2023 - nature.com
Atypical teratoid/rhabdoid tumors (ATRTs) represent a rare, but aggressive pediatric brain
tumor entity. They are genetically defined by alterations in the SWI/SNF chromatin …
tumor entity. They are genetically defined by alterations in the SWI/SNF chromatin …
Atypical teratoid rhabdoid tumor: proposal of a diagnostic pathway based on clinical features and neuroimaging findings
Purpose: To assess the main imaging and clinical features in adult-and pediatric-onset
atypical teratoid rhabdoid tumor (ATRT) in order to build a predefined pathway useful for the …
atypical teratoid rhabdoid tumor (ATRT) in order to build a predefined pathway useful for the …
Children's Oncology Group's 2023 blueprint for research: central nervous system tumors
Tumors of the central nervous system (CNS) are a leading cause of morbidity and mortality
in the pediatric population. Molecular characterization in the last decade has redefined CNS …
in the pediatric population. Molecular characterization in the last decade has redefined CNS …
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumor
SA Upadhyaya, O Campagne, CA Billups… - Neuro …, 2023 - academic.oup.com
Background Recurrent atypical teratoid/rhabdoid tumor (AT/RT) is, most often, a fatal
pediatric malignancy with limited curative options. Methods We conducted a phase II study …
pediatric malignancy with limited curative options. Methods We conducted a phase II study …
DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts
QT Tran, SA Upadhyaya, CA Billups… - Acta …, 2023 - Springer
Atypical teratoid/rhabdoid tumors (ATRT) are malignant embryonal tumors, most often
presenting in children under three years of age [7]. Three consensus ATRT molecular …
presenting in children under three years of age [7]. Three consensus ATRT molecular …